This company has been marked as potentially delisted and may not be actively trading. NASDAQ:IBBJ Defiance Nasdaq Junior Biotechnology ETF (IBBJ) Price, Holdings, & News Add Share Share Stock Analysis Stock AnalysisBuy This Stock About Defiance Nasdaq Junior Biotechnology ETF (NASDAQ:IBBJ) 30 days 90 days 365 days Advanced Chart Get IBBJ alerts:Sign Up Key Stats Today's Range$29.87▼$29.8750-Day Range$29.87▼$29.9452-Week Range$27.85▼$41.45VolumeN/AAverage Volume4,475 shsMarket Capitalization$7.47 millionAssets Under Management$2.54 millionDividend Yield1.00%Net Expense Ratio0.45%Aggregate RatingN/A ETF Overview Read More Defiance Nasdaq Junior Biotechnology ETF ExpensesTypeIBBJEquity ETFsNASDAQ ETFsAll ETFsManagement Fee0.45%0.56%0.54%0.53%Other Expenses0.00%0.56%0.52%0.56%Total Expense0.45%0.76%0.74%0.73%Fee Waiver0.00%-0.66%-0.50%-0.63%Net Expense0.45%0.63%0.63%0.60% Receive IBBJ Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Defiance Nasdaq Junior Biotechnology ETF and its competitors with MarketBeat's FREE daily newsletter. Email Address IBBJ ETF News HeadlinesDefiance Quantum ETF Price, Quotes and Forecasts | NASDAQ:QTUM | BenzingaMay 26, 2025 | benzinga.comiShares Biotechnology ETF (NASDAQ:IBB), Short Interest ReportFebruary 24, 2025 | benzinga.comThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in crypto. Now it’s back, and the smart money is already positioning. A free training reveals the step-by-step strategy and altcoin picks designed to help you capitalize on the next wave.July 4 at 2:00 AM | Crypto Swap Profits (Ad)LLYX Defiance Daily Target 2X Long LLY ETFSeptember 18, 2024 | seekingalpha.comSMCX Defiance Daily Target 2X Long SMCI ETFAugust 30, 2024 | seekingalpha.comNautilus Biotechnology Stock (NASDAQ:NAUT) Insider TradesFebruary 21, 2024 | benzinga.comSee More Headlines IBBJ ETF - Frequently Asked Questions What other stocks do shareholders of Defiance Nasdaq Junior Biotechnology ETF own? Based on aggregate information from My MarketBeat watchlists, some other companies that Defiance Nasdaq Junior Biotechnology ETF investors own include ARK Genomic Revolution ETF (ARKG), Plug Power (PLUG), Alkaline Water (WTER), Albemarle (ALB), Alpha Lithium (APHLF), ARK Fintech Innovation ETF (ARKF) and Ameriwest Lithium (AWLID). Fund Details IssuerDefiance ETFs Fund NameDefiance Nasdaq Junior Biotechnology ETF Tax ClassificationRegulated Investment Company Stock ExchangeNASDAQCurrent SymbolNASDAQ:IBBJ Inception Date8/4/2020 Fund ManagerDustin Lewellyn, Ernesto Tong, Anand Desai WebN/A PhoneN/AFund Focus Asset ClassEquity BenchmarkNasdaq Junior Biotechnology Index CategoryHealth Care FocusSector Development LevelBlended Develoment RegionGlobal Number of Holdings0 Fund Statistics Assets Under Management$2.54 million Average Daily Volume$0.00 Discount/Premium0.00% Administrator, Advisor and Custodian AdministratorU.S. Bancorp Fund Services, LLC AdvisorDefiance ETFs, LLC CustodianU.S. Bank, N.A. DistributorForeside Fund Services, LLC Transfer AgentU.S. Bancorp Fund Services, LLC TrusteeN/A Lead Market MakerN/A Miscellaneous Outstanding Shares250,000BetaN/A Metaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free Report IBBJ Sector ExposureIBBJ Industry Exposure This page (NASDAQ:IBBJ) was last updated on 7/4/2025 by MarketBeat.com Staff From Our PartnersElon’s RevengeElon Musk and President Trump's new feud is all over the news... But what no one has reported – yet – is th...Altimetry | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored379 passengers walked away from thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredGold: Now legal tender in many statesThe perfect gold play right now? (currently under $10) Everything in the news now lines up perfectly for an...Stansberry Research | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Defiance Nasdaq Junior Biotechnology ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Defiance Nasdaq Junior Biotechnology ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
